StockNews.com Initiates Coverage on Streamline Health Solutions (NASDAQ:STRM)

Analysts at StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Stock Performance

Shares of STRM stock opened at $2.78 on Tuesday. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. The firm has a market capitalization of $11.73 million, a price-to-earnings ratio of -0.58 and a beta of 1.64. The business has a 50 day simple moving average of $2.62 and a 200 day simple moving average of $5.36.

Streamline Health Solutions (NASDAQ:STRM) last issued its quarterly earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%. The business had revenue of $4.48 million for the quarter.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.